Business, Drugs and Pharmaceuticals, Free News Articles, Product Launches, Software

NEW PRODUCT LAUNCH: Pharmaceutical Strategies Group (PSG) Announces Artemetrx Extend – Revolutionary Drug Management Reporting Tool Offers Powerful User Insights

DALLAS, Texas -- Artemetrx®, the industry's most preeminent platform for integrated drug cost management, is now even more robust with the launch of its new module, Artemetrx Extend™. With greater insights and analytics, Artemetrx Extend is a custom reporting tool that provides unparalleled data access through its user-friendly platform.

"Artemetrx delivers swift and easy access to valuable drug management insights. With Artemetrx Extend, our clients will be able to further tap into the rich integrated dataset of the Artemetrx platform," said Libby Johnson, PSG Chief Data and Analytics Officer. "Artemetrx Extend continues our long legacy of client advocacy and innovation, as the industry's best keeps getting better."

Can your organization quickly get its data-driven questions answered? Most plans get bogged down waiting for custom analytics when Artemetrx can respond in seconds. The major capabilities now available within Artemetrx Extend, through powerful filtering and drill downs, include the ability to:

* Determine how many members have medical claims associated with a diagnosis for a specific group

* Analyze the specific diagnoses that a particular drug is prescribed to treat for a population based on claims history

* Model the financial impact of switching from one preferred medication to another

* View spend and trend statistics on all drugs (specialty/non-specialty, medical/pharmacy) or search based on National Drug Code, Healthcare Common Procedure Coding System, or drug name

There are two versions of Artemetrx Extend available: Base Access is available for all users, and Power User Access is optional, allowing for custom report and dashboard building and the ability to save and share reports.

Artemetrx is a proprietary industry-leading web-based software for integrated drug management developed by Pharmaceutical Strategies Group. Artemetrx Extend is the latest in a series of innovations on the Artemetrx platform.

Learn more about how Artemetrx Extend: https://link.psgconsults.com/Artemetrx.Extend

About Artemetrx®

Artemetrx is a proprietary SaaS platform developed by Pharmaceutical Strategies Group (PSG), an EPIC company. As one of the first technology solutions in the market to integrate pharmacy and medical claims data for specialty drug cost management, Artemetrx continues to provide market-leading specialty drug insights to payers. It delivers unparalleled intelligence and line-of-sight into serious challenges perpetuating out-of-control drug costs and compromised patient outcomes.

More information: https://www.psgconsults.com/discoverartemetrx

About Pharmaceutical Strategies Group (PSG)

Pharmaceutical Strategies Group, an EPIC company, relentlessly advocates for clients as they navigate complex and ever-changing drug cost management challenges. PSG's innovative drug management solutions, including Artemetrx®, deliver actionable insights with exceptional financial and clinical value. PSG functions as a strategic partner through industry-leading intelligence and technologies to realize billions of dollars in drug cost savings for clients every year.

More information: https://www.psgconsults.com/

Related link: https://www.psgconsults.com/

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022

Business, Free News Articles, Product Launches, Software, Taxes and Accounting

Advalent Launches Network 360 to Drive Multi-Dimensional Provider Performance in Value-Based Care Contracting

WESTBOROUGH, Mass. -- Advalent, a market-leading healthcare technology company focusing on payer solutions announced today the launch of a new network contracting and analytics product - Network 360(TM). Designed for payers and risk bearing healthcare providers, Network 360 is a breakthrough analytics platform that analyzes network, enables value-based contracting, and manages both upside and downside risk.

The new SaaS, cloud-based platform facilitates multi-dimensional provider performance assessment across quality, risk score adjustment (RAF) accuracy, cost, care and utilization to drive both short-term and long-term financial and clinical improvements in a format that is finally easy to use, understand, take action on.

Network 360(TM) proprietary analytical models enable decision makers to analyze network adequacy and assess overall population risk to devise the right value-based contracting and downstream provider arrangements to enable high performing provider collaboration programs. The platform's architecture leverages advanced bi-directional EMR connectors that not only consume EMR data, (in CCD/HL7/FHIR formats) but feeds actionable member insights into a provider's daily workflow.

The platform manages provider attribution and analyzes population/panel/member costs. It also utilizes trends, such as applicable risk and quality measures (RAF, HEDIS, and STARs) to create optimized care plan variations to assist providers in closing gaps and improving their overall performance.

"We are pleased to be one of the first healthcare technology companies to unlock the actionable insights required for plans to effectively and impactfully make the transition from fee for service to fee for value," said Brian Lichtlin CEO of Advalent.

"At Advalent, we believe that successful value-based programs hinge on a contracting team's ability to easily understand and target the provider characteristics that drive successful outcomes at reasonable prices in any region, for any specialty, and for any patient demographic group By finally delivering a tool that network contracting teams love, that also supports providers in care improvement, Advalent empower plans across the country to not only pay for value, but to create (nurture) it."

"With increased focus on value based contracting whether due to emerging MIPS/MACRA guidelines on the CMS end or the programs undertaken by leading private payers and health systems, it is extremely important for payers and provider groups to identify actionable ways to measure and improve provider performance," said Dr. Phani Kallakuri, Senior Medical Director. "Network360 allows holistic provider/network evaluation and provides ways to significantly improve network efficiencies by leveraging top performers and supporting low-performers through the right provider collaboration strategies."

The availability of Network 360(TM) platform will give providers more inclination to evolve from fee-for-service payment models to value-based care contracts. In fact, a recent study from Quest Diagnostics found 87 percent of physicians say they are likely to use a tool that provides on-demand, real-time, patient-specific data to identify gaps in quality, risk and utilization as well as medical history insight within clinical workflow. Network 360 gives analytical insights and develops actions plans to address these variations across members, providers and facilities (*Note 1).

About Advalent:
Advalent was founded in 2013 with the mission to advance core-administration technology used by Payer, Payviders and ACOs to compete in value-based care. They have created flexible, easy-to-use solutions that enable payers with the automation needed to increase operational efficiencies across multiple lines of business including Commercial, Medicaid, Medicare Advantage and Commercial Risk. Advalent has created a platform-as-a-service for the most complex value-based products to respond in real-time as the industry continues its push towards value-based care. More information: https://www.advalent.com/

(*Note 1) http://newsroom.questdiagnostics.com/2017-06-06-New-Study-Physicians-Lack-the-Right-Tools-to-Close-Costly-Gaps-in-Healthcare

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.